Mission Pharmacal
As of the edition of 20 October 2026, Mission Pharmacal runs 9 drugs, 8 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 8 |
| Stopped | 1 |
| Total | 9 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Alendronic acid | none listed | 3 |
| Potassium citrate anhydrous | none listed | 0 |
| Tinidazole | none listed | 0 |
| Potassium | none listed | 0 |
| Powdered cellulose | none listed | 0 |
| Tiopronin | Ended 2026 (exclusivity) | 0 |
| Acetohydroxamic acid | none listed | 0 |
| Cellulose sodium phosphate | none listed | 0 |
A route B row is one company at one target.
Where its trials are
- Pregnancy and women's health: 1 trials led
- Urinary and reproductive: 1 trials led